Details for New Drug Application (NDA): 207355
✉ Email this page to a colleague
The generic ingredient in POSACONAZOLE is posaconazole. There are twenty-one drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the posaconazole profile page.
Summary for 207355
Tradename: | POSACONAZOLE |
Applicant: | Actavis Labs Fl Inc |
Ingredient: | posaconazole |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 100MG | ||||
Approval Date: | Nov 30, 2022 | TE: | RLD: | No |
Complete Access Available with Subscription